Regulation of human Mcl-1 by a divergently-expressed antisense transcript
Related Experiment Video
Updated: Dec 12, 2025

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
S M Ali Hosseini Rad1, Grace Min Yi Tan1, Aarati Poudel1
1Department of Microbiology and Immunology, University of Otago, Dunedin 9010, Otago, New Zealand.
Abstract:
Mcl-1 is a member of the Bcl-2 anti-apoptotic protein family with important roles in the development, lifespan and metabolism of lymphocytes, as well as oncogenesis. Mcl-1 displays the shortest half-life of all Bcl-2 family members, with miRNA interference and proteasomal degradation being major pathways for Mcl-1 downregulation. In this study, we have identified a previously undescribed control mechanism active at the RNA level. A divergently transcribed lncRNA LOC107985203 (named here mcl1-AS1) negatively modulated Mcl-1 expression resulting in downregulation of Mcl-1 at both mRNA and protein level in a time-dependent manner. Using reporter assays, we confirmed that the mcl1-AS1 lncRNA promoter was located within Mcl-1 coding region. We next placed mcl1-AS1 under tetracycline-inducible control and demonstrated decreased viability in HEK293 cells upon doxycycline induction. Inhibition of mcl1-AS1 with shRNA reversed drug sensitivity. Bioinformatics surveys predicted direct mcl1-AS1 lncRNA binding to Mcl-1 transcripts, suggesting its mechanism in Mcl-1 expression is at the transcriptional level, consistent with a common role for anti-sense transcripts. The identification of a bi-directional promoter and lncRNA controlling Mcl-1 expression will have implications for controlling Mcl-1 activity in cancer cells, or for the purpose of enhancing the lifespan and quality of anti-cancer T lymphocytes.
Insights
Researchers discovered a new RNA mechanism controlling Mcl-1 (myeloid cell leukemia 1) expression. This long non-coding RNA, mcl1-AS1, downregulates Mcl-1, impacting cell viability and offering potential cancer therapy targets.
Area of Science:
- Molecular Biology
- Cancer Biology
- RNA Biology
Background:
- Mcl-1 (myeloid cell leukemia 1) is a key anti-apoptotic protein in the Bcl-2 family, crucial for lymphocyte function and implicated in oncogenesis.
- Mcl-1 has a short half-life, primarily regulated by miRNA and proteasomal degradation.
- Existing regulatory mechanisms do not fully explain Mcl-1 expression control.
Purpose of the Study:
- To identify novel regulatory mechanisms controlling Mcl-1 expression at the RNA level.
- To characterize the function and mechanism of a newly identified long non-coding RNA (lncRNA) affecting Mcl-1.
- To explore the therapeutic potential of targeting this regulatory pathway in cancer.
Main Methods:
- Reporter assays to confirm promoter location.
- Tetracycline-inducible system to control mcl1-AS1 expression.
- shRNA to inhibit mcl1-AS1.
- Bioinformatics analysis for RNA-RNA interactions.
- Cell viability assays (HEK293 cells).
Main Results:
- A novel lncRNA, mcl1-AS1, was identified that negatively regulates Mcl-1 expression at both mRNA and protein levels.
- The promoter for mcl1-AS1 is located within the Mcl-1 coding region, indicating a divergent transcription mechanism.
- Inducible expression of mcl1-AS1 decreased HEK293 cell viability, while its inhibition reversed drug sensitivity.
- Bioinformatics predicted direct binding of mcl1-AS1 to Mcl-1 transcripts, suggesting transcriptional regulation.
Conclusions:
- A novel bi-directional promoter and lncRNA (mcl1-AS1) regulatory axis controlling Mcl-1 expression has been identified.
- This finding provides new insights into Mcl-1 regulation beyond miRNA and proteasomal pathways.
- Targeting the mcl1-AS1/Mcl-1 interaction may offer therapeutic strategies for cancer and enhance anti-cancer T lymphocyte function.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
Abnormal Proliferation
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

